Finding the smoking gun: protein tyrosine phosphatases as tools and targets of unicellular microorganisms and viruses
Language English Country United Arab Emirates Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
22360485
DOI
10.2174/092986712799828274
PII: CMC-EPUB-20120222-008
Knihovny.cz E-resources
- MeSH
- Bacteria drug effects enzymology MeSH
- Bacterial Proteins antagonists & inhibitors metabolism MeSH
- Enzyme Inhibitors chemistry pharmacology MeSH
- Host-Pathogen Interactions MeSH
- Leishmania drug effects enzymology MeSH
- Humans MeSH
- Protozoan Proteins antagonists & inhibitors metabolism MeSH
- Reactive Oxygen Species metabolism MeSH
- Protein Tyrosine Phosphatases antagonists & inhibitors metabolism MeSH
- Viral Proteins antagonists & inhibitors metabolism MeSH
- Viruses drug effects enzymology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Bacterial Proteins MeSH
- Enzyme Inhibitors MeSH
- Protozoan Proteins MeSH
- Reactive Oxygen Species MeSH
- Protein Tyrosine Phosphatases MeSH
- Viral Proteins MeSH
Protein tyrosine phosphatases (PTPs) are increasingly recognized as important effectors of host-pathogen interactions. Since Guan and Dixon reported in 1990 that phosphatase YopH serves as an essential virulence determinant of Yersinia, the field shifted significantly forward, and dozens of PTPs were identified in various microorganisms and even in viruses. The discovery of extensive tyrosine signaling networks in non-metazoan organisms refuted the moth-eaten paradigm claiming that these organisms rely exclusively on phosphoserine/phosphothreonine signaling. Similarly to humans, phosphotyrosine signaling is thought to comprise a small fraction of total protein phosphorylation, but plays a disproportionately important role in cell-cycle control, differentiation, and invasiveness. Here we summarize the state-of-art knowledge on PTPs of important non-metazoan pathogens (Listeria monocytogenes, Staphylococcus aureus, Porphyromonas gingivalis, Caulobacter crescentus, Yersinia, Synechocystis, Leishmania, Plasmodium falciparum, Entamoeba histolytica, etc.), and focus also at the microbial proteins affecting directly or indirectly the PTPs of the host (Mycobacterium tuberculosis MTSA-10, Bacillus anthracis anthrax toxin, streptococcal β protein, Helicobacter pylori CagA and VacA, Leishmania GP63 and EF-1α, Plasmodium hemozoin, etc.). This is the first review summarizing the knowledge on biological activity and pharmacological inhibition of non-metazoan PTPs, with the emphasis of those important in host-pathogen interactions. Targeting of numerous non-metazoan PTPs is simplified by the fact that they act either as ectophosphatases or are secreted outside of the pathogen. Interfering with tyrosine phosphorylation represents a powerful pharmacologic approach, and even though the PTP inhibitors are difficult to develop, lifting the fog of phosphatase inhibition is of the great market potential and further clinical impact.
References provided by Crossref.org